The value of apoA-I in predicting heart disease and myocardial infarction
- 1 December 2015
- journal article
- Published by Taylor & Francis in Clinical Lipidology
- Vol. 10 (6) , 525-541
Abstract
Ischemic heart disease is the leading cause of death worldwide, accounting for approximately 11% of all deaths in 2011. Numerous studies have shown that cardiovascular risk correlates positively and powerfully with total or LDL-cholesterol (LDL-C) and correlates inversely with HDl-cholesterol (HDL-C). Much effort has spent comparing proatherogenic cholesterol markers LDL-C, non-HDL-C, apoB and LDL particle number, while little effort has been spent comparing the markers of the antiatherogenic marker apoA-I and HDL-C. Therefore, this review focused on comparing apoA-I and HDL-C in the prediction of heart disease and myocardial infarction. We identified 28 studies of which 12 indicated that the HDL-C was likely to be a superior marker of risk for heart disease and myocardial infarction compared with eight studies that identified apoA-I to be a superior marker of risk.Keywords
This publication has 32 references indexed in Scilit:
- Apolipoprotein B/Apolipoprotein A-I Ratio and Apolipoprotein BAngiology, 2013
- How Do Apolipoproteins ApoB and ApoA-I Perform in Patients with Acute Coronary SyndromesJournal of Medical Biochemistry, 2011
- The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controlsEuropean Heart Journal, 2009
- The correlation of apolipoprotein B, apolipoprotein B/apolipoprotein A-I ratio and lipoprotein(a) with myocardial infarctionOpen Medicine, 2008
- Prognostic value of lipoproteins and their relation to inflammatory markers among patients with coronary artery diseaseInternational Journal of Cardiology, 2005
- Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM)American Heart Journal, 2004
- Value of HDL Cholesterol, Apolipoprotein A-I, Lipoprotein A-I, and Lipoprotein A-I/A-II in Prediction of Coronary Heart DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprololAtherosclerosis, 1997
- Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 menAtherosclerosis, 1997
- Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery diseaseJACC, 1992